VELCADE-Thalidomide-Dexamethasone (VTD) vs Thalidomide-Dexamethasone (TD) Incorporated Into Double Autotransplantation for Untreated Multiple Myeloma (MM)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01134484 |
Recruitment Status : Unknown
Verified July 2012 by Michele Cavo, IRCCS Azienda Ospedaliero-Universitaria di Bologna.
Recruitment status was: Active, not recruiting
First Posted : June 2, 2010
Last Update Posted : July 20, 2012
|
Sponsor:
Michele Cavo
Collaborator:
Janssen-Cilag S.p.A.
Information provided by (Responsible Party):
Michele Cavo, IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Unknown |
---|---|
Actual Primary Completion Date : | August 2008 |
Estimated Study Completion Date : | December 2015 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):